Glaxo onboards promotional doctors

Share this article:

GlaxoSmithKline made a bit of a wave when it announced in December that it would no longer pay doctors to promote its drugs or to attend medical conferences.

Now comes part two: While Glaxo will not pay external doctors to talk up its drugs, it will hire doctor employees who will then go out into the field to discuss the company's drugs, reports Bloomberg.

Bloomberg reports that the new strategy will result in fewer doctors talking on GSK's behalf, and that this new crew has an added benefit: no need to report these payments under the Sunshine Act because these physicians work for GSK and are not presented as a disinterested party. Bloomberg posits this may knock GSK PhDs into being equated with medical science liaisons because these doctors will not be able to offer medical advice and are not practicing physicians.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Payment database confounds doctors

ProPublica reports that doctors are struggling with a time-intensive registration process and are getting an error message that CMS says is not an error message.

Gilead's idelalisib hat trick

The FDA greenlighted the drug for three cancers.

Shire expands rare disease reach

A $225-million deal with US biotech ArmaGen gives Shire worldwide commercialization rights to an experimental enzyme replacement therapy.